Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Congenital syphilis: update and perspectives].

C Hoarau1, V Ranivoharimina, M S Chavet-Quéru

  • 1Service de néonatalogie de l'hôpital Gatien de Clocheville, CHU de Tours, 49, bd Béranger, 37000 Tours, France.

Sante (Montrouge, France)
|April 22, 1999
PubMed
Summary

Congenital syphilis presents diverse symptoms in newborns, from mild to fatal. Early diagnosis and appropriate penicillin treatment are crucial for managing this infection and preventing reinfection.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pediatric neurolisteriosis: A diagnosis to consider even in the absence of immunodeficiency.

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie·2019
Same author

Comments on Ben Mansour et al: Additional cases of multifocal fixed drug eruption to ceftazidime.

Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology·2018
Same author

[X<sup>e</sup> International Congress of the Société de pathologie exotique, 8-9 November 2017, Haiphong (Vietnam) - Surgery Access in Tropical Areas].

Bulletin de la Societe de pathologie exotique (1990)·2018
Same author

A multicentre, prospective, non-randomized, sequential, open-label trial to demonstrate the bioequivalence between intravenous immunoglobulin new generation (IGNG) and standard IV immunoglobulin (IVIG) in adult patients with primary immunodeficiency (PID).

La Revue de medecine interne·2017
Same author

Treatment with Hizentra in patients with primary and secondary immunodeficiencies: a real-life, non-interventional trial.

BMC immunology·2016
Same author

Does the route of immunoglobin replacement therapy impact quality of life and satisfaction in patients with primary immunodeficiency? Insights from the French cohort "Visages".

Orphanet journal of rare diseases·2016

Area of Science:

  • Neonatal Medicine
  • Infectious Diseases
  • Pediatrics

Background:

  • Congenital syphilis, a preventable infection, manifests with a wide spectrum of clinical presentations in newborns.
  • It can range from asymptomatic cases to severe, life-threatening septicemic forms.

Observation:

  • Commonly observed symptoms include low birth weight, hepatosplenomegaly, and jaundice.
  • Other potential signs are premature birth, anemia, skin lesions, coryza, anasarca, and pseudoparalysis.
  • Radiographic findings may reveal characteristic but nonspecific osteochondritis and periostitis.

Findings:

  • Diagnosis relies on detecting specific IgM antibodies in newborns via immunofluorescence.
  • Symptomatic neonates require parenteral antibiotic therapy, typically penicillin for 15 days.

Related Experiment Videos

  • Treatment for asymptomatic congenital syphilis remains debated, with benzathine penicillin injection offered as a balance between surveillance and intensive treatment.

    • Implications:

    • Post-treatment serological monitoring for IgM or IgG antibody titers is essential to confirm treatment efficacy and detect potential reinfection.
    • Effective management necessitates addressing socioeconomic and cultural factors contributing to syphilis prevalence, particularly in developing nations.
    • Enhanced awareness and robust national programs are vital for controlling congenital syphilis globally.